Skip to content


Influencing and Monitoring PEPFAR Country Programs
By Lotti Rutter, Associate Director, International Policy and Advocacy, Health GAP

Scaling Up TB Preventive Therapy Advocacy in PEPFAR 2020 COPs
By Lynette Mabote, Health Activist/TAG Consultant

LAM Testing in 2020 PEPFAR COPs
By David Branigan, TAG TB Project Officer

Advocacy to Ensure the Prioritization of Hepatitis C in PEPFAR COPs
By Bryn Gay, TAG HCV Project Director

By Helen Bygrave and Jessica Burry, MSF Access Campaign

On January 22, 2020, Treatment Action Group (TAG), Médecins Sans Frontières (MSF) Access Campaign, Health GAP, IMPAACT4TB, and AVAC presented this  webinar on how to engage in PEPFAR COPs advocacy and promote the prioritization of interventions that address HIV coinfections and AIDS.

HIV coinfections such as tuberculosis (TB), cryptococcal meningitis, and hepatitis put the lives of people living with HIV/AIDS at risk and must be prioritized within life-saving bilateral efforts such as PEPFAR. The development of PEPFAR Country Operational Plans (COPs) for FY2020 provides a critical opportunity for advocates to ensure that the latest developments in preventing, diagnosing, and treating HIV coinfections and AIDS are implemented within PEPFAR programs.

The webinar was moderated by Lotti Rutter, Health GAP’s Associate Director, International Policy and Advocacy, and the introduction and closing were done by Suraj Madoori, TAG’s U.S. and Global Health Policy Director.

For more information on engaging the PEPFAR COPs process and for the 2020 COPs timeline, please see Health GAP’s Rough Guide to Influencing and Monitoring PEPFAR Country Programs.


Back To Top